NFKB1 and metabolic dysfunction-associated steatotic liver disease: Western blotting results showed that the high-dose DPS (DPSH group) significantly reduced RAGE expression and NF-κB p65 protein phosphorylation in the liver of NAFLD mice (p < 0.05) (Figure 5).